Kemia

Description

Kémia, Inc. is a private company that discovers and develops novel small molecule therapeutics targeting validated high value disease targets not yet addressed by safe and effective orally active drugs. Kémia's proprietary chemistries are focused in two promising areas: allosteric kinase inhibitors and modulators of G protein-coupled receptors (GPCRs).

Companies nearby